Medtronic (NYSE: MDT) today announced new data supporting its Aurora and OmniaSecure defibrillation technology offerings.

Patients with heart failure (HF) and left ventricular (LV) dysfunction have been shown to derive clinical benefit from cardiac resynchronization therapy (CRT) and from implantable ...

Implantable cardioverter-defibrillators (ICDs) reduce mortality in patients with increased risk of sudden cardiac death, but use of these devices has been limited by complications with the ...

Elderly patients diagnosed with congestive heart failure who receive implantable cardioverter-defibrillators for primary prevention of sudden cardiac death live longer than those that do not. Further, ...

In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...

Giulio Molon, M.D.; Cosimo Perrone, M.D.; Massimiliano Maines, M.D.; Alessandro Costa, M.D.; Jennifer Comisso, M.D.; Alida Boi, M.D.; Eugenio Moro, M.D.; Giuseppe ...

A study of heart failure patients who meet national guidelines for devices that stabilize and strengthen the heart's electrical system found that only half of eligible patients received the devices.

NEW YORK, Jan. 8, 2019 /PRNewswire/ -- Implantable Cardioverter Defibrillator (ICD Devices) Devices (Cardiovascular Devices) - Global Market Analysis and Forecast Model Read the full report: Summary ...

Researchers have discovered that implantable cardioverter-defibrillators (ICDs) -- electric monitoring devices that deliver a lifesaving shock in the event of a cardiac arrest -- help patients with ...

COPENHAGEN, June 17 (Reuters) - Christian Eriksen's soccer career could be saved by an implantable cardioverter defibrillator or ICD, a small battery-powered device to regulate his heartbeat following ...

CHICAGO (Reuters) - Boston Scientific Corp's new leadless implantable heart defibrillator, hailed by some as a breakthrough, should be used on a limited basis until more data are collected, a ...

Background: Multiple clinical trials have shown that a properly functioning implantable cardioverter-defibrillator (ICD) is capable of interrupting sudden death caused by ventricular tachyarrhythmias.